Literature DB >> 7349320

The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs.

J F Prescott.   

Abstract

Fifty-one isolates of Corynebacterium equi recovered from pigs and horses belonging to two capsular serotypes were tested for susceptibility to antimicrobial agents. No clear differences were detected in sensitivity between isolates of different sources or serotypes. All isolates were sensitive to less than 0.25 micrograms/ml of erythromycin and gentamicin. The following minimum inhibitory concentrations (MICs) of antimicrobial agents were determined for greater than or equal to 90% of isolates: methicillin greater than 16 micrograms/ml, clindamycin 1-2 micrograms/ml, tobramycin less than or equal to 1 microgram/ml, cephalothin 8-64 micrograms/ml, kanamycin 2-8 micrograms/ml, amikacin less than or equal to 1-2 micrograms/ml, penicillin 2-greater than or equal to 4 micrograms/ml, ampicillin 2-8 micrograms/ml, trimethoprim-sulfa 4/76-32/608 micrograms/ml tetracycline 1-4 micrograms/ml and chloramphenicol 8-16 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7349320     DOI: 10.1111/j.1365-2885.1981.tb00706.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Antimicrobial drug susceptibility of bacteria isolated from disease processes in cattle, horses, dogs and cats.

Authors:  J F Prescott; V P Gannon; G Kittler; G Hlywka
Journal:  Can Vet J       Date:  1984-07       Impact factor: 1.008

Review 2.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Diagnosing Rhodococcus equi infections in a setting where tuberculosis is highly endemic: a double challenge.

Authors:  Thuy Le; Shama Cash-Goldwasser; Phan Vinh Tho; Nguyen Phu Huong Lan; James I Campbell; H Rogier van Doorn; Nguyen Tien Lam; Nguyen Vu Trung; Dao Tuyet Trinh; Nguyen Van Kinh; Heiman F L Wertheim
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.